Data on Navidea’s AZD4694 Presented by the Banner Institute at the 6th Annual Human Amyloid Imaging Meeting (HAI)
DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) today announced that the Banner Alzheimer’s Institute, Phoenix, AZ, made two presentations of results from an AstraZeneca-sponsored study on the assessment of Navidea’s late-stage radiopharmaceutical imaging candidate, AZD4694, at the 6th Annual Human Amyloid Imaging Meeting (HAI), in Miami, FL. In December 2011, Navidea in-licensed the worldwide exclusive rights to AZD4694 from AstraZeneca, now being developed by Navidea as a radiopharmaceutical agent for the detection of cerebral amyloid in Alzheimer’s disease (AD) patients.
“[18F] AZD4694 PET in the Assessment of Fibrillar Amyloid–β Deposition: Performance Characteristics”
the two poster presentations, titled, “[18F] AZD4694 PET Quantification for the Assessment of Fibrillar Amyloid–β Deposition” and “[18F] AZD4694 PET in the Assessment of Fibrillar Amyloid–β Deposition: Performance Characteristics,” provide additional evidence that [18F] AZD4694 offers promise in the assessment of fibrillar Amyloid–β (Aβ) deposition. Fibrillar Amyloid–β PET ligands may provide useful tools in the scientific study, early detection, tracking and differential diagnosis of Alzheimer’s disease and the evaluation of Aβ-modifying treatments.
the findings in this study indicate that [18F] AZD4694 PET in the assessment of fibrillar Aβ deposition in Alzheimer’s disease is feasible and relatively straightforward with common analysis methodologies.
“We look forward to conducting additional studies to assess the safety and efficacy of this imaging agent as a potentially effective tool to aid the diagnosis of patients with Alzheimer’s disease, a devastating disease that is reaching high levels in the United States and around the world,” said Jessica Langbaum, staff scientist at the Banner Alzheimer’s Institute.
the Banner Institute presentations at HAI described the use of [18F] AZD4694 in the examination of fibrillar Aβ burden as an aid in the diagnosis of AD. the objective of the first part of the Banner study was to determine an analysis setting for examining the differential fibrillar Aβ burden in three different groups: i) subjects with mild Alzheimer’s dementia (n=8), ii) elderly healthy controls (oHC)(n=9), and iii) young normal controls who were not carriers of apolipoprotein E (APOE) ε4 (yNC)(n=4). Results indicate that individual images and the ability to distinguish between subject groups undergoing evaluation with AZD4694 were roughly comparable using two evaluation methods, Distribution Volume Ratio (Logan method and simplified Logan method) and Standard Uptake Ratio, used during various scan intervals, different cerebellar reference regions, and pre-injection versus post-emission transmission scans.
In addition, differences between groups in the AZD4694 PET measurements were seen:
the 8 AD subjects had higher signals than the 9 oHC subjects presumably due to their higher amyloid level; the 8 AD subjects also had higher signals that the 4 yNC subjects; and the 9 oHC subjects had higher signals than the 4 yNC subjects.
the second part of the study used [18F] AZD4694 to characterize fibrillar Aβ burden in subjects with probable mild Alzheimer’s disease (n=8, 4 APOE ε4 carriers and 4 non-carriers), healthy elderly control subjects (n=9, 5 APOE ε4 carriers and 4 non-carriers) and healthy younger controls (n=5, all APOE ε4 non-carriers). the study objective was to assess group differences in fibrillar Aβ, effect of apolipoprotein E (APO) ε4, and test-retest reliability (assessed using a second scan of AD and yNC subjects) of [18F] AZD4694. the results indicate that AZD4694 demonstrated rapid equilibrium and favorable Central Nervous system uptake/distribution, a relatively high specific signal-to-white matter background binding thus permitting reader-friendly images, the ability to distinguish between the participant groups, and high test-retest reliability as assessed in 3 AD and 4 yNC subjects.
While Navidea undertakes arrangements to commence its Phase III clinical program in early 2013, a number of additional ongoing and planned studies to build the requisite safety and training database will provide further information on AZD4694 during this year.
About Alzheimer’s
Alzheimer’s disease (AD) is a progressive and fatal neurodegenerative disease which affects a person’s memory and ability to learn, reason, communicate and carry out daily activities. Increasing age is the greatest risk factor for AD and there is no prevention or cure. the World Health Organization estimates that Alzheimer’s disease affects over 24,000,000 people worldwide. currently in the U.S. alone, there are over 5 million Alzheimer’s patients with estimates that by 2050, as many as 16 million Americans could have the disease according to the Alzheimer’s Association. Among the brain changes believed to contribute to the development of Alzheimer’s are the accumulation of the protein beta-amyloid outside nerve cells (neurons) in the brain and the accumulation of the protein tau inside neurons. Approximately 75 to 100 experimental therapies aimed at diagnosing, slowing or stopping the progression of Alzheimer’s are now in human clinical trials.
About AZD4694
AZD4694 is a Fluorine-18 labeled precision radiopharmaceutical candidate for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as AD. It binds to Beta-amyloid deposits in the brain that can then be imaged in positron emission tomography (PET) scans. Amyloid plaque pathology is a required feature of AD diagnosis and the presence of amyloid pathology is a supportive feature for diagnosis of probable AD. Patients who are negative for amyloid pathology do not have AD.
About Navidea Biopharmaceuticals
Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Navidea is actively developing three radiopharmaceutical agent platforms – Lymphoseek®, AZD4694 and RIGScanTM – to help identify the presence and status of undetected disease and enable better diagnostic accuracy, clinical decision-making and ultimately patient care. Navidea’s strategy is to deliver superior growth and shareholder return by bringing to market novel radiopharmaceutical agents and advancing the Company’s pipeline through selective acquisitions, global partnering and commercialization efforts. For more information, please visit www.navidea.com.
The Private Securities Litigation Reform Act of 1995 (the Act) provides a safe harbor for forward-looking statements made by or on behalf of the Company. Statements in this news release, which relate to other than strictly historical facts, such as statements about the Company’s plans and strategies, expectations for future financial performance, new and existing products and technologies, anticipated clinical and regulatory pathways, and markets for the Company’s products are forward-looking statements within the meaning of the Act. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” and similar expressions identify forward-looking statements that speak only as of the date hereof. Investors are cautioned that such statements involve risks and uncertainties that could cause actual results to differ materially from historical or anticipated results due to many factors including, but not limited to, the Company’s continuing operating losses, uncertainty of market acceptance of its products, reliance on third party manufacturers, accumulated deficit, future capital needs, uncertainty of capital funding, dependence on limited product line and distribution channels, competition, limited marketing and manufacturing experience, risks of development of new products, regulatory risks and other risks detailed in the Company’s most recent Annual Report on Form 10-K and other Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements.
<a href="http://www.businesswire.com/news/home/20120119006634/en/Data-Navidea%E2%80%99s-AZD4694-Presented-Banner-Institute-6thtag:news.google.com,2005:cluster=http://www.businesswire.com/news/home/20120119006634/en/Data-Navidea’s-AZD4694-Presented-Banner-Institute-6thFri, 20 Jan 2012 22:50:06 GMT”>Data on Navidea’s AZD4694 Presented by the Banner Institute at the 6th Annual Human Amyloid Imaging Meeting (HAI)
The Seven Essential "Stations" Every Home Should Have
When organizing our clients’ homes, we teach people there are some common “stations” that virtually every home should have. Here are the seven that we feel are most important:
1. Destination Station – This station belongs where you come in and out of the house. It’s where you put all of your things down when you come in, such as purses, keys, and backpacks. We often drill a hole in the back of a drawer and run a power cord through the back of it for cell phone chargers. You can use simple shelving, you can convert an existing coat closet, or you can use a piece of “mud room” or entryway furniture like this one shown from Pottery Barn.
2. Communication Station – This station is for the family calendar, messages, mail, and other communications that help the house run smoothly. One thing that we encourage is having a Family Binder that will contain all of the frequently-used information such as contacts, medical records, school handouts and lists, and sports team rosters and schedules.
3. Donation Station – every home should have a designated place to collect items for donation, and when it’s full, the items can be taken to your favorite charity drop-off location. It’s also helpful to keep a clipboard here for listing the items you add to the pile, so that when it’s tax time, you will be better able to value your donations.
4. Gift and Shipping Station – You may not have a permanent station set up for this one, but at least gather all of these items together in a bin or drawer for easy retrieval when you need them. You should have gift wrap, scissors, tape, and all of the other items needed for wrapping and mailing.
5. Education Station – This station is the homework and reference area, mostly for the kids. You’ll need a comfortable flat surface, preferably a desk, where the kids can do their work. There should be good lighting, good chairs, plenty of office supplies, paper, a dictionary, a thesaurus, and probably a computer in this area. And don’t forget peace and quiet!
6. Creation Station – Homes with children and/or other artists need to have a place to paint, draw, sew, or pursue other creative outlets. Craft and art supplies can be stored here, nearby an available surface to work with plenty of light. like the Gift & Shipping Station, you may not have this station set up permanently. We like using rolling plastic drawer carts for a mobile version of this station that fits easily in a coat closet.
7. Administration Station – Also known as the home office, this station is where the bills get paid, forms get filled out, medical claims are filed, and phone calls are made. Here you’ll need a desk, storage for all office supplies, a computer and printer, a filing cabinet and filing supplies, and a comfortable, functional chair. This station is where all of your basic office systems are centralized.
Lorie Marrero is a Professional Organizer and creator of The Clutter Diet, an innovative, affordable online program for home organization. Lorie’s site helps members lose “Clutter-Pounds” from their home by providing online access to her team of organizers. Lorie writes something useful, funny, interesting, and/or insanely practical every few days or so in the Clutter Diet Blog. She lives in Austin, TX, where her company has provided hands-on organizing services to clients since 2000.
Quick Learning Guide for: VistA Computerized Patient Record System Electronic Health Records Software Reviews
Quick Learning Guide for: VistA Computerized Patient Record System Electronic Health Records Software
INDEPENDENT, RIGOROUS, & OBJECTIVE: The Quick Learning Guide gives a quick and comprehensive walk through the Veterans Health Information Systems and Technology Architecture Computerized Patient Record (VistA CPRS) software. VistA CPRS is used in the Veterans Administration (VA) hospitals and outpatient clinics, and in medical facilities around the world. VistA CPRS software is available for free to anyone as download from the Veteran’s Administration website. The Quick Learning Guide covers how
List Price: $ 99.99
Price: $ 77.38
Prolexic Issues Dirt Jumper Threat Advisory and Releases Free Security Scanner
Hollywood, Florida USA (PRWEB) December 29, 2011
Prolexic Technologies, the global leader in Distributed Denial of Service (DDoS) mitigation services, today announced it has issued a threat advisory for Dirt Jumper, a high-risk DDoS toolkit that can be used to launch application layer attacks on web sites. Prolexic has also developed a security-scanning tool that can be used to detect Dirt Jumper command and control servers. The threat advisory and scanner can be downloaded free of charge from http://www.prolexic.com/threatadvisories
Dirt Jumper is a prepackaged toolkit that has evolved from the Russkill strain of malware. It is now widely available on various underground websites and retails for as little as US$ 150. Dirt Jumper can be spread via spam, exploit kits, fake downloads and can be pushed out to machines already infected with other forms of malware.
The Dirt Jumper DDoS toolkit is currently one of the most aggressive malware strains used by DDoS attackers globally, said Neal Quinn, vice president of operations at Prolexic. Increasingly, we are seeing this tool used against clients worldwide and it is likely to become more widespread and effective as distribution spreads.
After analyzing the Dirt Jumper v3 DDoS Toolkit, the Prolexic Security Engineering and Response Team (PLXSERT) categorized it as a high-risk threat. The Prolexic team identified the newest variant, known as Dirt Jumper September and uncovered that it had updated functionalities as well as an enhanced control panel, which makes it simple for attackers to use. Prolexics Dirt Jumper Threat Advisory provides an analysis of the payload and also gives a detailed breakdown of attack signatures by attack type, as well as information on remediation and recommended mitigation strategies.
PLXSERT has also written a custom-scanning tool called Dirt Dozer (dirtdozer.py) that enables security research teams and engineers to validate if any suspected HTTP command and control servers utilize any strains of the malware. As a public service to business enterprises and organizations worldwide, Prolexics Dirt Dozer scanner is being made available free of charge and can be downloaded from http://www.prolexic.com/threatadvisories
Prolexic Threat Advisories
Prolexic recently launched a service that provides its subscribers with regular Threat Advisories. Compiled by the Prolexic Security Engineering and Response Team (PLXSERT), on-going advisories will help subscribers stay informed and vigilant so they can make better, proactive decisions.
Designed to provide early warnings of new or modified DDoS attack signatures and scripts recently observed by PLXSERT, each Threat Advisory contains a detailed description of the type of attack, a list of attack signatures, and the specific network infrastructure or application that it targets. In addition, Prolexics DDoS mitigation experts also offer insight into the nature of each type of attack, as well as provide specific warnings as to how the attack will affect businesses and enterprises of different sizes and infrastructures. PLXSERT also provides threat remediation tips to help subscribers not only recognize the new attack signatures, but also proactively defend against them.
The more our subscribers understand about DDoS attacks, the more they will be able to make informed decisions about DDoS protection and mitigation strategies, said Paul Sop, chief technology officer at Prolexic. As the industrys premium provider, Prolexic is ideally positioned to provide this unique level of insight and intelligence to our customers.
New Threat Advisories will be distributed to subscribers via email and will also be posted on the Prolexic Portal, a password protected, subscriber-only resource.
About the Prolexic Security Engineering & Response Team (PLXSERT)
PLXSERT monitors malicious cyber threats globally and analyzes DDoS attacks using proprietary techniques and equipment. Through data forensics and post attack analysis, PLXSERT is able to build a global view of DDoS attacks, which is shared with customers. By identifying the sources and associated attributes of individual attacks, the PLXSERT team helps organizations adopt best practices and make more informed, proactive decisions about DDoS threats.
About Prolexic
Prolexic is the worlds largest, most trusted Distributed Denial of Service (DDoS) mitigation provider. Able to absorb the largest and most complex attacks ever launched, Prolexic restores mission critical Internet facing infrastructures for global enterprises and government agencies within minutes. Six of the worlds ten largest banks and the leading companies in e-Commerce, payment processing, travel/hospitality, gaming and other at-risk industries rely on Prolexic to protect their businesses. Founded in 2003 as the worlds first in the cloud DDoS mitigation platform, Prolexic is headquartered in Hollywood, Florida and has scrubbing centers located in the Americas, Europe and Asia. For more information, visit http://www.prolexic.com.
Contact:
Michael E. Donner
Lifepoint Informatics Participating at 4th G2 Intelligence Annual LabCompete
GLEN ROCK, NJ (PRWEB) December 04, 2011
Lifepoint Informatics announced its support of G2 Intelligences 4th Annual LabCompete: Laboratory Sales & Marketing Conference being held December 12 14 in Chandler, Arizona. Lifepoint Informatics is a Silver Sponsor of this premier event that provides in-depth coverage along with insights and strategies for Laboratory Outreach management. In addition to Silver Sponsorship, Lifepoint Informatics senior management will be on hand to provide information on its extensive line of laboratory connectivity products including EMRHub, Outreach MD and its ONC Certified LPI Web Provider Portal.
The proliferation of EMR vendors has made implementing and transitioning to electronic medical records (EMR) quite a challenge for hospital, medical center and clinical laboratory IT departments, with IT staff scrambling to keep pace with the connectivity demands that interfacing to these disparate systems require. With more and more physicians utilizing EMRs, labs need to have the right technology in place to seamlessly integrate EMRs and EHRs into their existing systems to remain competitive. EMRHub provides efficient and hassle free LIS to EMR interfacing and is vendor neutral so it works with any EMR or EHR.
When quick access to lab results is needed, physicians on the move turn to Outreach MD, one of Lifepoints mobile solutions enabling providers to access results on hand-held devices such as the iPhone, iPad, Blackberry, Android, and other smartphones. The Outreach MD application provides for secure result delivery and review with the convenience and portability of the smart phone and iPad.
Lifepoints LPI Web Provider Portal can help labs, hospitals, ACOs and all healthcare organizations meet the demand for connectivity with providers via browser-based, on-demand, superior portal solutions. LPI Web Provider Portal gives providers access to the most current data anytime from anywhere to help reduce turn-around-time and improve patient care. LPI Web Provider Portal works with existing HIS and LIS systems to leverage existing infrastructure and optimize the current IT investment.
For additional information about Lifepoint Informatics and its full line of HIT products, please visit http://www.lifepoint.com. For more information regarding LabCompete: Laboratory Sales & Marketing Conference, visit http://www.labcompete.com.
About Lifepoint Informatics: Lifepoint Informatics is a leader in healthcare IT serving the data connectivity, integration and communication needs of clinical laboratories, hospitals and health networks. Lifepoint Informatics develops, sells and supports healthcare information technology solutions nationwide to help healthcare providers improve patient care and lower costs through the use of information technology. Since 1999, Lifepoint Informatics has enabled over 200 hospitals, clinical labs and anatomic pathology groups to grow their market share and extended their outreach programs through the deployment of its ONC certified Web Provider Portal and its comprehensive portfolio of ready-to-go EMR and EHR interfaces. For more Information please visit http://www.lifepoint.com.
Media Contact: Emily Ruffing
201-447-3991 ext. 349
###
Practice Manager X3-Single Database Practice Management Software
Practice Manager X3-Single Database Practice Management Software
- Hipaa compliant
- Support’s all practices that bill on a CMS 1500 claim form
- Claim status reporting and tracking
- BC Advantage readers choice award 2006 (ease of use)
- The automatic payment posting module allows users to post an entire EOB in mere seconds.
Practice Manager X3 provides practice management, billing and scheduling functions that meet or exceed other high end products without the hefty price-tag, in an easy to use and understand format.
Practice Manager X3 manages the information integral to insurance billing, account collections, managed care, practice marketing, and accounts receivable.
List Price: $ 1,299.00
Price: $ 899.00
eDoctor, Inc. Announces e-Prescribing Integration Service for OpenEMR Vendors
Rockville, MD. (PRWEB) December 31, 2011
eDoctor, Inc., an innovative provider of Healthcare IT solutions, now offers Surescripts-certified Newcrop electronic prescribing for OpenEMR vendors seeking to integrate safe, easy e-Prescribing within their OpenEMR. Available through an exclusive partnership with Newcrop, eDoctors e-Prescribing meets and exceeds all Medicare MIPPA requirements for federal e-Prescribing incentives; through use of a Newcrop engine, eDoctors e-Prescribing software meets the original OpenEMR Meaningful Use certification criteria for “additional required software. eDoctors e-Prescribing is an ideal solution for OpenEMR providers seeking a state-of-the-art electronic prescribing solution that is easily integrated within the OpenEMR to meet Meaningful Use criteria.
eDoctors e-Prescribing is the best choice for OpenEMR vendors who need a Newcrop-powered e-Prescribing solution, said Se Kang, President of eDoctor. Secure, easy e-Prescribing is a necessary component for Meaningful Use incentives.
The OpenEMR 4.1, a Meaningful Use-certified Ambulatory EMR developed by a team of physicians and programmers, requires additional software to meet Meaningful Use Stage One regulations. One of these software components is Newcrop e-Prescribing, available through eDoctors suite of Healthcare IT services, which easily integrates within the vendors OpenEMR system. Another component offered by eDoctor is the Integrated Laboratory Computerized Order and Entry System, a major Meaningful Use criterion which also integrates conveniently within the OpenEMR 4.1. Vendors offering the OpenEMR 4.1 must integrate these systems, and others, within the EMR to qualify for significant Medicare incentives. Providing affordable integration with a low cost per month per physician, eDoctor is the leading integrator for OpenEMR solutions; integrating eDoctors e-Prescribing and Laboratory CPOE is an effective decision for vendors seeking to offer clients an easy-to-use and affordable solution.
eDoctor, Inc. is a premier Health IT firm passionate about simplifying patient care through technology and exceptional service. We provide electronic prescribing, a Meaningful Use-certified electronic medical record system, and an exciting and innovative patient management system to doctors who wish to participate in Medicare incentive programs. Our clients are part of the growing Healthcare IT modernization movement to enhance office workflow and increase both patient safety and satisfaction. eDoctor proudly services over 3,500 healthcare providers across 36 states in a range of medical fields.
###
Medical Spanish – Virtual Conversations(R) Language Program
Medical Spanish – Virtual Conversations(R) Language Program
- Medical Spanish is for health professionals who want to converse with non-English-speaking Hispanic patients. A Spanish-speaking physician helps you pronounce all the medical history questions and phrases you will use in the medical interview.
- You can record and replay your pronunciation of the words and phrases; instantly compare your pronunciation to the tutor’s; have the system evaluate your pronunciation; see the English translations of the Spanish words and phrases.
- Virtual Conversations® Medical Spanish teaches vocabulary and phrases for use in clinical settings. Practice speaking by taking the medical history of a Hispanic woman who doesn’t speak English.
- Hear the native speaker’s pronunciation of the phrases. Ask medically relevant questions in Spanish and hear the patient answer in Spanish.
- Unique role-playing experience with powerful self-evaluating features that allow you to train your ear and approach accent-free speech.
Virtual Conversations® programs are the only multimedia foreign language programs that immerse you in realistic, give-and-take conversations with native speakers. This experience will rapidly increase your confidence in speaking Spanish. You will learn vocabulary quickly and naturally, and improve your listening, comprehension and reading skills. Medical Spanish includes a tutor, a Hispanic physician, who helps you learn to pronounce the questions and phrases you will use to interview a patient
List Price: $ 89.95
Price: $ 68.99
The Occupational Therapy Manager, Fourth Edition
The Occupational Therapy Manager, Fourth Edition
Incorporating the language of the Occupational Therapy Practice Framework: Domain and Process, this comprehensive volume draws on the knowledge of experts in a wide variety of fields, providing information and critical overviews of topics crucial to planning, organization, direction, evaluation, communication, business development, and more. It presents detailed and timely discussions of practical day-to-day functions and covers new topics for today’s profession, including community-based practi
List Price: $ 79.00
Price: $ 38.02
eDoctor, Inc. Announces New Integrated OpenEMR Solution
Rockville, MD (PRWEB) December 28, 2011
eDoctor, Inc., an innovative provider of Health IT solutions, now offers a Meaningful Use-certified Ambulatory EMR through the Open Source OpenEMR project. A state-of-the-art Web-based software system, the eDoctor OpenEMR is a comprehensive Health IT package providing numerous features including practice management, clinical management, and electronic billing. Integrated within the eDoctor OpenEMR are our certified NewCrop-powered e-Prescribing, the iON Laboratory Order and Entry System, and our new Patient Appointment and Management System- all designed to streamline office workflow, increase physician and patient satisfaction, and earn Medicare incentives.
We know how busy doctors are, said Se Kang, eDoctors President. We wanted to offer a system that could do everything for our clients within one convenient account- with an affordable cost and a clear data ownership policy.
The OpenEMR 4.1 is a ONC-ATB Ambulatory EMR certified for 2011-2012 Meaningful Use requirements. A multi-platform EMR, the OpenEMR 4.1 was originally developed by a team of physicians and programmers through the nonprofit OpenSource EMR foundation. The software is easily customizable, multilingual, and multi-facility capable- ideal for both smaller practices and larger clinics. Noted for its simplicity and ease of use, the OpenEMR is an excellent choice for practices transitioning from a paper-based to an electronic office. Use of the OpenEMR qualifies practices for Medicare Meaningful Use incentives totalling $ 44,000 over the next few years.
eDoctors training services and integration of the OpenEMR provide additional features to boost office efficiency and patient satisfaction. Included with our OpenEMR is our Surescripts-certified NewCrop e-Prescribing solution, through an exclusive partnership with NewCrop, and the iON Laboratory Computerized Physician Order Entry (CPOE) System, an exceptional patient laboratory results software powered by Atlas. The iON CPOE System provides access to online ordering and reporting, unifying patient results from participating labs onto one efficient and easily accessible page. Also built into the eDoctor OpenEMR is our new Patient Appointment and Management System, a unique Web-based portal which allows patients to search for doctors and book appointments online- increasing practice exposure and patient convenience while reducing empty appointment slots.
Unlike other EMR providers, eDoctor believes that the ownership of all gathered patient data belongs to the clinicians entrusted by the patient to manage their health records. eDoctor will not sell or use this entrusted data. In the spirit of the Open Source community, eDoctor will not charge for the OpenEMR platform; the only charge is for the implementation, setup, configuration, training, support, and maintenance of clients OpenEMR platform. Each OpenEMR is owned by the client, protecting them from future uncertainties that come with most EMR vendor solutions.
eDoctor, Inc. is a premier Health IT firm passionate about simplifying patient care through technology and exceptional service. We provide electronic prescribing, a Meaningful Use-certified electronic medical record system, and an exciting and innovative patient management system to doctors who wish to participate in Medicare incentive programs. Our clients are part of the growing Healthcare IT modernization movement to enhance office workflow and increase both patient safety and satisfaction. eDoctor proudly services over 3,500 healthcare providers across 36 states in a range of medical fields.
# # #